Difference between revisions of "Uterine tumours"
Jump to navigation
Jump to search
(→Uterine tumors resembling ovarian sex cord tumours: split out) |
|||
(12 intermediate revisions by the same user not shown) | |||
Line 7: | Line 7: | ||
=Common benign= | =Common benign= | ||
==Uterine leiomyoma== | ==Uterine leiomyoma== | ||
*Often called ''fibroids''. | *Often called ''fibroids''. | ||
{{Main|Uterine leiomyoma}} | |||
=Uncommon benign= | =Uncommon benign= | ||
Line 110: | Line 33: | ||
Images: | Images: | ||
*[ | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496288/figure/F2/ Adenofibroma (nlm.nih.gov)].<ref>{{cite journal |authors=Chawla L, Vatsa R, Roy KK, Kumar S |title=Uterine Adenofibroma: An Unsual Cause of Nonpuerperal Uterine Inversion in Postmenopausal Female |journal=J Midlife Health |volume=8 |issue=2 |pages=95–97 |date=2017 |pmid=28706412 |pmc=5496288 |doi=10.4103/jmh.JMH_27_17 |url=}}</ref> | ||
==Adenomatoid tumour== | ==Adenomatoid tumour== | ||
Line 120: | Line 42: | ||
==Smooth muscle tumour of uncertain malignant potential== | ==Smooth muscle tumour of uncertain malignant potential== | ||
*Abbreviated ''STUMP''. | *Abbreviated ''STUMP''. | ||
{{Main|Smooth muscle tumour of uncertain malignant potential}} | |||
=Malignant= | =Malignant= | ||
==Uterine carcinosarcoma== | ==Uterine carcinosarcoma== | ||
* [[AKA]] ''malignant mixed muellerian tumour'', abbreviated ''MMMT''. | * [[AKA]] ''malignant mixed muellerian tumour'', abbreviated ''MMMT''. | ||
{{Main|Uterine carcinosarcoma}} | |||
==Adenosarcoma of the uterus== | ==Adenosarcoma of the uterus== | ||
*[[AKA]] ''uterine | *[[AKA]] ''uterine adenosarcoma''. | ||
{{Main|Adenosarcoma of the uterus}} | |||
==Uterine leiomyosarcoma== | ==Uterine leiomyosarcoma== | ||
Line 262: | Line 81: | ||
*#**Zonal necrosis may be seen in (benign) leiomyomas. | *#**Zonal necrosis may be seen in (benign) leiomyomas. | ||
*#Mitoses. | *#Mitoses. | ||
*#*10 mitoses/HPF. | *#*10 mitoses/10 HPF. | ||
*#*5 mitoses/HPF - if epithelioid. | *#*5 mitoses/10 HPF - if epithelioid. | ||
*#*2 mitoses/HPF - if [[myxoid]]. | *#*2 mitoses/10 HPF - if [[myxoid]]. | ||
Note: | Note: |
Latest revision as of 15:26, 10 January 2022
This article deals with uterine tumours, with the exception of the tumours that arise from the endometrium.
Uterine tumours are like water in the sea - very very common. Many hysterectomies are done for them. The most common are leiomyomata (AKA fibroids).
Pre-malignant endometrium and endometrial tumours are dealt with in the articles, endometrial hyperplasia and endometrial carcinoma.
Common benign
Uterine leiomyoma
- Often called fibroids.
Main article: Uterine leiomyoma
Uncommon benign
Uterine adenofibroma
- AKA adenofibroma of the uterus.
General
- Uncommmon.
- Benign looking lesions can reoccur.[1]
- It has been proposed that these lesions are in fact well-differentiated adenosarcomas.[2]
Microscopic
Features:
- Moderately demarcated lesion with:
- Pale stroma and epithelioid/spindle cells.
- Simple cuboidal (or columnar) epithelium with eosinophilic cytoplasm.
- Low mitotic rate.
- Nuclear atypia minimal.
Note:
- Appearance similar to fibroadenoma.
DDx:
- Adenosarcoma.
Images:
Adenomatoid tumour
- Should not be confused with the bone tumour adamantinoma.
Main article: Adenomatoid tumour
Uncertain malignant potential
Smooth muscle tumour of uncertain malignant potential
- Abbreviated STUMP.
Main article: Smooth muscle tumour of uncertain malignant potential
Malignant
Uterine carcinosarcoma
- AKA malignant mixed muellerian tumour, abbreviated MMMT.
Main article: Uterine carcinosarcoma
Adenosarcoma of the uterus
- AKA uterine adenosarcoma.
Main article: Adenosarcoma of the uterus
Uterine leiomyosarcoma
Main article: Leiomyosarcoma
General
- Poor prognosis.
- Do not (generally) arise from leiomyomas.
- Often singular, i.e. one tumour; unlike leiomyomas (which are often multiple).
Gross
Features:
- "Fleshy" appearance.
- Necrosis.
- Large size.
- Often singular, i.e. one lesion; leiomyomata are often multiple.
Microscopic
Features:
- Smooth muscle differentiation - essential.
- Fascicular architecture.
- Whorled look at low power.
- Groups of spindle cells cut peripendicular to their long axis adjacent to groups of spindle cells cut in the plane of their long axis.
- May rely on IHC - if poorly differentiated.
- Fascicular architecture.
- Malignant histomorphologic features - two of three required - key features:[4]
- Nuclear pleomorphism.
- Coagulative tumour cell necrosis
- Should be patchy/multifocal.
- Zonal necrosis is suggestive of vascular cause and may be a degenerative change.
- Zonal necrosis may be seen in (benign) leiomyomas.
- Mitoses.
- 10 mitoses/10 HPF.
- 5 mitoses/10 HPF - if epithelioid.
- 2 mitoses/10 HPF - if myxoid.
Note:
- The mitotic rate seems to be a relatively weak predictor; a modest rate may be malignant and a high rate benign.[5]
DDx:
- Endometrial stromal sarcoma.
- Uterine carcinosarcoma.
- Undifferentiated endometrial sarcoma.
- Smooth muscle tumour of uncertain malignant potential.
- Uterine leiomyoma.
IHC
- CD10 -ve.
- Positive for SMC markers.
- Desmin - present in all three types of muscle.
- Caldesmon.
- Smooth muscle myosin.
- p16 +ve.[6]
- Useful for differentiation from leiomyoma.
Endometrial stromal tumours
This grouping includes the gamut from benign to malignant.
Overview
WHO classification:[7]
- Endometrial stromal nodule - not a tumour.
- Endometrial stromal sarcoma (ESS), low grade.
- Undifferentiated endometrial sarcoma (UES).
Notes:
- Some believe in a "high grade ESS"... some don't.[8]
Endometrial stromal nodule
- Abbreviated ESN.
General
- Benign.
Microscopic
Features:
- Well-circumscribed - key feature.
- No vascular invasion.
DDx:
- Endometrial stromal sarcoma (ESS), UES - myometrial invasion or vascular invasion.
Images:
Endometrial stromal sarcoma
- Abbreviated ESS.
- Previously known as low-grade endometrial stromal sarcoma.
Main article: Endometrial stromal sarcoma
Undifferentiated endometrial sarcoma
- Abbreviated as UES.
- Previously known as high-grade endometrial stromal sarcoma.[10]
General
- Malignant.
- Rare.
- This can be thought of as pleomorphic undifferentiated sarcoma in the uterus.
Microscopic
Features:
- Marked nuclear atypia.
- Mitoses+++.
- Poorly differentiated - key feature
- Looks nothing like low grade endometrial stromal sarcoma.
- Negative for smooth muscle markers (to exclude leiomyosarcoma).
Notes:
- Need IHC to diagnose.
DDx:
IHC
Features:[11]
- SMA ~50% +ve.
Typically negative:[11]
- Smooth muscle markers: desmin, h-caldesmon.
- Skeletal muscle markers: Myf4, actin.
- Melanoma: S100, HMB-45.
- GIST: CD117.
Weird stuff
Trophoblastic tumours
Uterine tumour resembling an ovarian sex cord stromal tumour
- Abbreviated UTROSCT.
Atypical polypoid adenomyoma of the uterus
- Abbreviated APA.
- AKA atypical polypoid adenomyoma.
Main article: Atypical polypoid adenomyoma of the uterus
See also
References
- ↑ Seltzer, VL.; Levine, A.; Spiegel, G.; Rosenfeld, D.; Coffey, EL. (Jun 1990). "Adenofibroma of the uterus: multiple recurrences following wide local excision.". Gynecol Oncol 37 (3): 427-31. PMID 2351327.
- ↑ Gallardo, A.; Prat, J. (Feb 2009). "Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.". Am J Surg Pathol 33 (2): 278-88. doi:10.1097/PAS.0b013e318181a80d. PMID 18941402.
- ↑ Chawla L, Vatsa R, Roy KK, Kumar S (2017). "Uterine Adenofibroma: An Unsual Cause of Nonpuerperal Uterine Inversion in Postmenopausal Female". J Midlife Health 8 (2): 95–97. doi:10.4103/jmh.JMH_27_17. PMC 5496288. PMID 28706412. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496288/.
- ↑ Ip, PP.; Cheung, AN. (Dec 2011). "Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.". Best Pract Res Clin Obstet Gynaecol 25 (6): 691-704. doi:10.1016/j.bpobgyn.2011.07.003. PMID 21865091.
- ↑ Guo, L.; Liu, T.; Huang, H. (Oct 1996). "[Reappraisal of the pathological criteria for uterine leiomyosarcoma].". Zhonghua Bing Li Xue Za Zhi 25 (5): 266-9. PMID 9388868.
- ↑ Gannon, BR.; Manduch, M.; Childs, TJ. (Jan 2008). "Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.". Int J Gynecol Pathol 27 (1): 68-73. doi:10.1097/pgp.0b013e3180ca954f. PMID 18156978.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 426. ISBN 978-0781765275.
- ↑ Amant F, Vergote I, Moerman P (November 2004). "The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned". Gynecol. Oncol. 95 (2): 412–3; author reply 413. doi:10.1016/j.ygyno.2004.07.021. PMID 15491769. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WG6-4DF46J8-3&_user=1166899&_coverDate=11%2F01%2F2004&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1204975755&_rerunOrigin=google&_acct=C000051839&_version=1&_urlVersion=0&_userid=1166899&md5=d6ec1eee2941460a085d1dac6615b5a5.
- ↑ Baker, P.; Oliva, E. (Mar 2007). "Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques.". J Clin Pathol 60 (3): 235-43. doi:10.1136/jcp.2005.031203. PMID 17347285. http://jcp.bmj.com/content/60/3/235.full.
- ↑ Feng, W.; Malpica, A.; Skaland, I.; Gudlaugsson, E.; Robboy, SJ.; Dalen, I.; Hua, K.; Zhou, X. et al. (2013). "Can proliferation biomarkers reliably predict recurrence in world health organization 2003 defined endometrial stromal sarcoma, low grade?". PLoS One 8 (10): e75899. doi:10.1371/journal.pone.0075899. PMID 24146786.
- ↑ 11.0 11.1 Abeler, VM.; Nenodovic, M. (May 2011). "Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases.". Int J Gynecol Pathol 30 (3): 236-43. doi:10.1097/PGP.0b013e318200caff. PMID 21464730.